|
|
|
Volumn 16, Issue 4, 2004, Pages 13-15
|
|
The pipeline: three to watch.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
DRUG APPROVAL;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
MALE;
VIRUS LOAD;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIALS;
DRUG APPROVAL;
FEMALE;
HIV FUSION INHIBITORS;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
MALE;
REVERSE TRANSCRIPTASE INHIBITORS;
VIRAL LOAD;
|
|
EID: 4644318692
PISSN: 1058708X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
